Tanmay Saraykar
PGC Analytics – How can it benefit patients?
For a long time before the realization of the Health 2.0 concept, a doctor was the only guide to patients for the smallest of health-related queries. Analytics of any sort were restricted to pharmaceutical companies who utilized them for commercial purposes. In a Health 2.0 world, there has been an explosion in patient generated content [...]
Hashtags and healthcare
Going by a recent estimate, about 110 million tweets are generated daily. That’s humongous! The amazing part is that the tweet volume is growing. Content of these tweets covers everything from a newly discovered meteor to the latest trends in fashion. Twitter is clutter in the true sense of the word and hashtags are a [...]
Insights about rheumatoid arthritis drugs from social media data
Patients of rheumatoid arthritis are very active on social networking sites such as Facebook, Twitter, blog and forums. RA patients are well aware of the medication they take for managing the disease such as NSAIDs, DMARDs and biologics and specifically mention brand names of prescription drugs. Comments from RA patients on social networks contain information [...]
Pharma/Healthcare Social Media Monitoring and Analysis – Challenges and how to address them – Part 2
In continuation of our last blog post about challenges faced while monitoring and analyzing social media data for healthcare, here are some more. 5) Unpredictability of buzz and viral nature of social media Rarely, any event in social media is entirely predictable. Many a times, companies don’t even realize that the most well intentioned [...]
Pharma/Healthcare Social Media Monitoring and Analysis – Challenges and how to address them – Part 1
In the recent years, the usually shy and conservative pharma/healthcare companies have made great strides in the social media space, and their activities extend well beyond basic consumer engagement. Using social media, pharma/healthcare companies have taken up multifarious activities such as spreading disease related awareness, patient education, product related research and gather consumer feedback [...]
PharmARC Social Media Analytics Webcast – Episode 1
Pharma/Healthcare industry is highly regulated and pharma marketers are often considered as a conservative lot. Traditionally, marketing communication in the healthcare industry has been corporate controlled, top-down, unidirectional, non-interactive and cautious. However, with the advent of new web-based communication and publication technologies and proliferating social networks, the way pharm/healthcare companies market and engage consumers [...]
American Diabetes Association Scientific Session Conference – Twitter Buzz Analysis
From its initial days, Twitter has come a long way from being a web based tool used for following daily activities of friends to a PR tool for live –blogging during offline events and spreading news. Although during the recent times, the pharma/healthcare companies are waking up to social media’s potential for connecting with patients, [...]
Aricept 23 mg dose being taken off? Both sides of the story.
In this new era of patients, caregivers, physicians, pharmacists, companies and others expressing and sharing their thoughts and opinions, it is imperative to understand their perceptions on therapy areas and various treatment options. Typically, triggers generate series of discussions and comments. In this case, Public Citizen Petition to FDA to ban the 23 mg dose [...]
ASCO 2011 – Post Conference Social Media Buzz – Analysis by PharmARC
The American Society of Clinical Oncology (ASCO) 2011 conference concluded on June 8, 2011 in Chicago. The overwhelming response it received in Chicago resounded equally strongly online on various social media websites such as Twitter, LinkedIn and Facebook. And that gets our team at PharmARC excited! This annual conference on oncology was attended by leading [...]
